BACKGROUND: Our aim was to evaluate the prevalence and relationship of symptoms with reduced dietary intake, weight, and functional capacity in patients with head and neck cancer. METHODS: Three hundred forty-one patients were prospectively screened with the patient-generated subjective global assessment before treatment. Logistic analysis was used to relate symptoms to reduced dietary intake, weight, and functional capacity. Cumulative hazard analysis was performed to determine the time and risk of weight loss of each symptom. Survival analysis was performed with Cox proportional hazards model. RESULTS: Anorexia, dysphagia, mouth sores, and others were significant predictors of reduced dietary intake and weight. Symptom presence accelerated the time and probability of weight loss. Body mass index < or = 18.5 related to overall survival (p value = .001). CONCLUSIONS: Symptoms present before treatment may adversely affect the dietary intake, weight, and functional capacity of patients. Symptom treatment and management is critical to weight loss prevention.
BACKGROUND: Our aim was to evaluate the prevalence and relationship of symptoms with reduced dietary intake, weight, and functional capacity in patients with head and neck cancer. METHODS: Three hundred forty-one patients were prospectively screened with the patient-generated subjective global assessment before treatment. Logistic analysis was used to relate symptoms to reduced dietary intake, weight, and functional capacity. Cumulative hazard analysis was performed to determine the time and risk of weight loss of each symptom. Survival analysis was performed with Cox proportional hazards model. RESULTS: Anorexia, dysphagia, mouth sores, and others were significant predictors of reduced dietary intake and weight. Symptom presence accelerated the time and probability of weight loss. Body mass index < or = 18.5 related to overall survival (p value = .001). CONCLUSIONS: Symptoms present before treatment may adversely affect the dietary intake, weight, and functional capacity of patients. Symptom treatment and management is critical to weight loss prevention.
Authors: Mona Kamal; Martha P Barrow; Jan S Lewin; Alicia Estrella; G Brandon Gunn; Quiling Shi; Theresa M Hofstede; David I Rosenthal; Clifton David Fuller; Katherine A Hutcheson Journal: Support Care Cancer Date: 2018-09-14 Impact factor: 3.603
Authors: Julia Furtner; Els Genbrugge; Thierry Gorlia; Martin Bendszus; Martha Nowosielski; Vassilis Golfinopoulos; Michael Weller; Martin J van den Bent; Wolfgang Wick; Matthias Preusser Journal: Neuro Oncol Date: 2019-12-17 Impact factor: 12.300
Authors: Sanli Jin; Qian Lu; Dong Pang; Yan Sun; Shaowen Xiao; Baomin Zheng; Hangjing Cui Journal: Support Care Cancer Date: 2019-04-04 Impact factor: 3.603
Authors: Julia R Van Liew; Rebecca L Brock; Alan J Christensen; Lucy Hynds Karnell; Nitin A Pagedar; Gerry F Funk Journal: Head Neck Date: 2016-10-05 Impact factor: 3.147
Authors: A Navigante; P Cresta Morgado; O Casbarien; N López Delgado; R Giglio; M Perman Journal: Support Care Cancer Date: 2013-01-16 Impact factor: 3.603
Authors: M Gobbo; G Ottaviani; G Perinetti; F Ciriello; A Beorchia; M Giacca; R Di Lenarda; K Rupel; G Tirelli; S Zacchigna; M Biasotto Journal: Support Care Cancer Date: 2014-02-20 Impact factor: 3.603
Authors: Ylva Tiblom Ehrsson; Per M Hellström; Kerstin Brismar; Lena Sharp; Ann Langius-Eklöf; Göran Laurell Journal: Support Care Cancer Date: 2009-10-15 Impact factor: 3.603
Authors: M González-Rodríguez; R Villar-Taibo; A Fernández-Pombo; M Pazos-Couselo; M A Sifontes-Dubón; S Ferreiro-Fariña; A Cantón-Blanco; M A Martínez-Olmos Journal: Eur J Clin Nutr Date: 2020-10-23 Impact factor: 4.016